According to the authors, MMP1 levels in early CRC stages (II and III) were associated with an increased likelihood of distant metastasis, whereas rectal cancer in stage III recurrence was rather associated with MMP2 [186]. This evidence concerns the gene MMP2 and colorectal carcinoma.